In the SUSTAIN FORTE clinical trials, participants in the semaglutide (Ozempic) group showed an average reduction of 2.2 percentage points in the HbA1c levels with a 2 mg weekly dosage and 1.9 percentage points with a 1 mg weekly dosage of semaglutide after 40 weeks
By measuring specific biomarkers, your healthcare provider can evaluate factors such as blood sugar levels, lipid profile, hormonal balance, inflammation markers, and more, which play crucial roles in managing obesity and type 2 diabetes
Note: Quotes represent the opinions of our medical experts
For a deeper single-compound overview, see the Semaglutide Canada research guide
This creates a feedback loop where sensitivity breeds more sensitivity
Here are some practical tips to help you succeed: Prioritize protein at every meal